butylscopolammonium bromide has been researched along with reboxetine in 1 studies
| Studies (butylscopolammonium bromide) | Trials (butylscopolammonium bromide) | Recent Studies (post-2010) (butylscopolammonium bromide) | Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) |
|---|---|---|---|---|---|
| 695 | 165 | 149 | 626 | 193 | 184 |
| Protein | Taxonomy | butylscopolammonium bromide (IC50) | reboxetine (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.0018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carberry, JC; Eckert, DJ; Grunstein, R; Lim, R; Wellman, A | 1 |
1 trial(s) available for butylscopolammonium bromide and reboxetine
| Article | Year |
|---|---|
Reboxetine and hyoscine butylbromide improve upper airway function during nonrapid eye movement and suppress rapid eye movement sleep in healthy individuals.
Topics: Adult; Airway Resistance; Australia; Butylscopolammonium Bromide; Cross-Over Studies; Double-Blind Method; Electromyography; Female; Humans; Male; Nose; Parasympatholytics; Pharyngeal Muscles; Pharynx; Polysomnography; Pressure; Reboxetine; Respiration; Scopolamine; Sleep; Sleep Apnea, Obstructive; Sleep, REM; Tongue; Wakefulness | 2019 |